DK169234B1 - Farmaceutisk præparat til prophylaxe og behandling af retrovirusinfektioner - Google Patents

Farmaceutisk præparat til prophylaxe og behandling af retrovirusinfektioner Download PDF

Info

Publication number
DK169234B1
DK169234B1 DK037187A DK37187A DK169234B1 DK 169234 B1 DK169234 B1 DK 169234B1 DK 037187 A DK037187 A DK 037187A DK 37187 A DK37187 A DK 37187A DK 169234 B1 DK169234 B1 DK 169234B1
Authority
DK
Denmark
Prior art keywords
interferon
tnf
cells
virus
hiv
Prior art date
Application number
DK037187A
Other languages
Danish (da)
English (en)
Other versions
DK37187A (da
DK37187D0 (da
Inventor
Grace Hing-Wah Wong
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/822,099 external-priority patent/US4828830A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK37187D0 publication Critical patent/DK37187D0/da
Publication of DK37187A publication Critical patent/DK37187A/da
Application granted granted Critical
Publication of DK169234B1 publication Critical patent/DK169234B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK037187A 1986-01-24 1987-01-23 Farmaceutisk præparat til prophylaxe og behandling af retrovirusinfektioner DK169234B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/822,099 US4828830A (en) 1986-01-24 1986-01-24 Method and composition for prophylaxis and treatment of viral infections
US82209986 1986-01-24
US89253186A 1986-07-31 1986-07-31
US89253186 1986-07-31

Publications (3)

Publication Number Publication Date
DK37187D0 DK37187D0 (da) 1987-01-23
DK37187A DK37187A (da) 1987-07-25
DK169234B1 true DK169234B1 (da) 1994-09-19

Family

ID=27124616

Family Applications (1)

Application Number Title Priority Date Filing Date
DK037187A DK169234B1 (da) 1986-01-24 1987-01-23 Farmaceutisk præparat til prophylaxe og behandling af retrovirusinfektioner

Country Status (11)

Country Link
EP (1) EP0235906B1 (zh)
JP (1) JP2510181B2 (zh)
CN (1) CN1023295C (zh)
AU (1) AU598225B2 (zh)
CA (1) CA1296252C (zh)
DE (1) DE3765137D1 (zh)
DK (1) DK169234B1 (zh)
ES (1) ES2031882T3 (zh)
GR (1) GR3001091T3 (zh)
IL (1) IL81367A0 (zh)
NZ (1) NZ219027A (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1290249C (en) * 1986-04-09 1991-10-08 Cetus Corporation COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
AU633525B2 (en) * 1988-11-15 1993-02-04 Sanwa Kagaku Kenkyusho Co., Ltd. Enhancers for biosynthetic interferon and compositions containing them as well as preparations for making aids asymptomatic and curing aids and compositions therefor
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
EP0421023B1 (de) * 1989-10-06 1995-03-15 MUCOS EMULSIONSGESELLSCHAFT m.b.H. Katabolische Enzyme zur Induktion des Tumornekrose-Faktors (TNF)
EP0554381B2 (en) * 1990-10-25 2000-04-26 Genentech, Inc. Use of protective agents against reactive oxygen species
ES2214551T3 (es) * 1995-11-02 2004-09-16 Schering Corporation Terapia de infusion continua de citocinas a baja dosis.
EP1415655A4 (en) * 2001-07-19 2005-12-21 Akira Hayashi IMMUNOTHERAPY FOR PEOPLE
CN105031620A (zh) * 2015-07-14 2015-11-11 天津瑞普生物技术股份有限公司 一种针对鸡胚的禽呼肠孤病毒抑制方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2513124B1 (fr) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab Production et applications du facteur de lyse des cellules-cibles
IL71954A0 (en) * 1983-06-01 1984-09-30 Genentech Inc Gamma interferon-lymphotoxin synergism
CA1265444A (en) * 1983-06-27 1990-02-06 Lloyd J. Old Effect of human tumor necrosis factor and human interferon on human cancer cells and methods
DE3423234A1 (de) * 1984-06-23 1986-02-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Synergistische mischungen von interferonen und tumor-nekrose-faktor
GR851626B (zh) * 1984-07-05 1985-11-26 Genentech Inc
JP2557053B2 (ja) * 1984-12-21 1996-11-27 バイオジェン インコーポレイテッド 腫瘍壊死因子の精製、製造および使用法
JPS6287525A (ja) * 1985-10-15 1987-04-22 Kanegafuchi Chem Ind Co Ltd 新規リンホトキシン含有抗腫瘍剤
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
PT85076B (pt) * 1986-06-16 1990-07-31 Genentech Inc Metodo para o tratamento de doencas infecciosas pela administracao de factor de necrose tumoral-alfa

Also Published As

Publication number Publication date
EP0235906B1 (en) 1990-09-26
IL81367A0 (en) 1987-08-31
CA1296252C (en) 1992-02-25
AU6796287A (en) 1987-07-30
CN87100480A (zh) 1987-11-11
AU598225B2 (en) 1990-06-21
GR3001091T3 (en) 1992-04-17
NZ219027A (en) 1989-09-27
ES2031882T3 (es) 1993-01-01
JPS62215535A (ja) 1987-09-22
JP2510181B2 (ja) 1996-06-26
CN1023295C (zh) 1993-12-29
EP0235906A1 (en) 1987-09-09
DK37187A (da) 1987-07-25
DE3765137D1 (de) 1990-10-31
DK37187D0 (da) 1987-01-23

Similar Documents

Publication Publication Date Title
Poli et al. Interferon-α but not AZT suppresses HIV expression in chronically infected cell lines
Kornbluth et al. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.
Pensiero et al. Hantaan virus infection of human endothelial cells
Kannagi et al. Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro
CN1094642A (zh) 治疗组合物
CZ231998A3 (cs) Použití konvenčního interferonu
DK169234B1 (da) Farmaceutisk præparat til prophylaxe og behandling af retrovirusinfektioner
YAMADA et al. Inhibition of growth of HIV by human natural interferon in vitro
Matsuyama et al. Enhancement of HIV replication and giant cell formation by tumor necrosis factor
PITHA Multiple effects of interferon on HIV-1 replication
KROWN Interferon-α: Evolving Therapy for AIDS-Associated Kaposi's Sarcoma
Nakashima et al. Recombinant human interferon gamma suppresses HTLV‐III replication in vitro
US4828830A (en) Method and composition for prophylaxis and treatment of viral infections
Khyatti et al. The effect of indometacin, prostaglandin E2 and interferon on the multiplication of herpes simplex virus type 1 in human lymphoid cells
EP0956040B1 (en) Stimulation of host defense mechanisms against viral challenges
KR100394382B1 (ko) 천연사람α-인터페론으로구성된약학조성물
Pugliese et al. Interleukin‐18 enhances HIV‐1 production in a human chronically‐infected T cell line (H9‐V)
GB2194146A (en) Treatment of retroviral infections
Anderson et al. Effects of tumor necrosis factor-α treatment on mortality in murine cytomegalovirus-infected mice
Lane The role of immunomodulators in the treatment of patients with AIDS
Sneller Consensus symposium on combined antiviral therapy; overview of interferon and IL-2 combinations for the treatment of HIV infection
Mitsuyasu Use of recombinant interferons and hematopoietic growth factors in patients infected with human immunodeficiency virus
US6080726A (en) Anti-viral and immuno stimulator polynucleotide duplex and use thereof
US20240139293A1 (en) Compositions and Methods for Enhancing Anti-Viral Therapies
HU201679B (en) Process for producing synergetic pharmaceutical compositions against retrovirus contaminations

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired